Daniel M. Hancock - Sep 27, 2021 Form 4 Insider Report for Cryoport, Inc. (CYRX)

Role
Director
Signature
/s/ Daniel Hancock
Stock symbol
CYRX
Transactions as of
Sep 27, 2021
Transactions value $
-$558,222
Form type
4
Date filed
9/29/2021, 04:47 PM
Previous filing
Sep 7, 2021
Next filing
Oct 22, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYRX Common Stock Options Exercise $144K +10K +216.12% $14.35 14.6K Sep 27, 2021 Direct F1
transaction CYRX Common Stock Sale -$702K -10K -68.37% $70.17 4.63K Sep 27, 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYRX Option to purchase common stock Options Exercise $0 -10K -40% $0.00 15K Sep 27, 2021 Common Stock 10K $14.35 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2021.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.65 to $70.47, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 1/12 of these options vested and became exercisable in equal monthly installments on the 2nd of each month for the twelve (12) months beginning on 05/02/2019.